UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 4 | April 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 8 Issue 8
August-2021
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2108330


Registration ID:
314015

Page Number

c626-c633

Share This Article


Jetir RMS

Title

An Article on Pneumonia in Covid-19

Abstract

Coronaviruses are large group of viruses that cause illness in humans and animals.Rarely, animal coronaviruses can evolve and infect people and then spread between people such as has been seen with and SARS outbreak in 2003 which started from China.The outbreak of Novel coronavirus disease (COVID-19) was initially noticed in a seafood market in Wuhan city in Hubei Province of China in mid-December, 2019, has now spread to 215 countries worldwide WHO declared COVID-19 a pandemic on 11th March, 2020. ACE-2 receptor has been identified as a functional receptor for SARS-CoV and is highly expressed on the pulmonary epithelial cells. Ranges from 1 to 14 days. Median incubation period around 5 days. Period of infectivity: from 2 days before symptom onset to around 7 to 10 days after Symptom onset. Autopsy findings have revealed that endothelial damage of pulmonary vasculature & micro vascular thrombosis and extensive alveolar and interstitial inflammation (known as diffuse alveolar damage) DAD. Macro vascular Thrombosis in Pulmonary and other Large and Medium sized Vessels cause large areas of Consolidation in the Lungs. One study found that 66 out of 70 people who had COVID-19 pneumonia still had lung lesions visible by CT scan when they left the hospital. A recent study Trusted Source followed up on 71 individuals 15 years after they had SARS, which develops from a related coronavirus. The researchers found that lung lesions decreased significantly in the year after recovery. However, after this recovery period, the lesions plateaued. Most people who get COVID-19 have mild or moderate symptoms like coughing, a fever, and shortness of breath. But some who catch the new coronavirus get severe pneumonia in both lungs. COVID-19 pneumonia is a serious illness that can be deadly.

Key Words

Pneumonia,Covid-19

Cite This Article

"An Article on Pneumonia in Covid-19", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.8, Issue 8, page no.c626-c633, August-2021, Available :http://www.jetir.org/papers/JETIR2108330.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"An Article on Pneumonia in Covid-19", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.8, Issue 8, page no. ppc626-c633, August-2021, Available at : http://www.jetir.org/papers/JETIR2108330.pdf

Publication Details

Published Paper ID: JETIR2108330
Registration ID: 314015
Published In: Volume 8 | Issue 8 | Year August-2021
DOI (Digital Object Identifier):
Page No: c626-c633
Country: Surat, Gujarat, India .
Area: Biological Science
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000487

Print This Page

Current Call For Paper

Jetir RMS